Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02RCY
|
|||
| Drug Name |
PMID29649907-Compound-41
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
NOVARTIS AG CHIANELLI, Donatella LIU, Xiaodong MOLTENI, Valentina NELSON, John ROLAND, Jason RUCKER, Paul TULLY, David
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C28H21ClF2N4O5
|
|||
| Canonical SMILES |
CN1C2=C(COC3=C2C=C(C=C3)Cl)C(=N1)C(=O)N(CC4=CC(=CC=C4)F)CC(=O)NC5=C(C=CC(=C5)C(=O)O)F
|
|||
| InChI |
1S/C28H21ClF2N4O5/c1-34-26-19-11-17(29)6-8-23(19)40-14-20(26)25(33-34)27(37)35(12-15-3-2-4-18(30)9-15)13-24(36)32-22-10-16(28(38)39)5-7-21(22)31/h2-11H,12-14H2,1H3,(H,32,36)(H,38,39)
|
|||
| InChIKey |
VJLVLEHRWCLRBO-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Farnesoid X-activated receptor (FXR) | Target Info | Agonist | [1] |
| Target's Patent Info | Farnesoid X-activated receptor (FXR) | Target's Patent Info | [1] | |
| KEGG Pathway | Bile secretion | |||
| Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | |||
| Reactome | Recycling of bile acids and salts | |||
| PPARA activates gene expression | ||||
| Endogenous sterols | ||||
| WikiPathways | Nuclear Receptors in Lipid Metabolism and Toxicity | |||
| Nuclear Receptors Meta-Pathway | ||||
| Farnesoid X Receptor Pathway | ||||
| Drug Induction of Bile Acid Pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Farnesoid X receptor modulators 2014-present: a patent review.Expert Opin Ther Pat. 2018 May;28(5):351-364. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.